LNSR
LENSAR, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$8.58
+4.00%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
2.6x
Market Cap
$105.41M
MomentumView details →
1D Return
+4.00%
YTD Return
−27.00%
RSI (14)
63.0
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
2.6x
Market Cap
$105.41M
RSI (14)
63.0
MomentumView details →
1D Return
+4.00%
YTD Return
−27.00%
SummaryUpdated Jun 1, 2026
LENSAR, Inc. (NASDAQ:LNSR) is a commercial-stage medical device company founded in 2004 and headquartered in Orlando, Florida. The company went public in October 2020 and specializes in developing femtosecond laser systems for cataract surgery and corneal astigmatism management. LENSAR has established itself as a significant player in the laser-assisted cataract surgery market, with approximately 21% market share in the United States and over 385 systems installed globally as of 2024.
Similar companies
Latest newsMore news →